Back to results
US 2026/0062465 A1Published application
Human Immunodeficiency Virus Neutralizing Antibodies and Methods of Use Thereof
AssigneesThe Rockefeller University, California Institute of Technology
InventorsJohannes Scheid, Michel Nussenzweig, Pamela J. Bjorkman, Ron Diskin
Life of this patent
Estimating the term…
Abstract
The invention provides broadly neutralizing antibodies directed to epitopes of Human Immunodeficiency Virus, or HIV. The invention further provides compositions containing HIV antibodies used for prophylaxis, and methods for diagnosis and treatment of HIV infection.
Claims20
An isolated anti-HIV gp120 antibody or an antigen-binding fragment thereof comprising a set of heavy chain complementarity determining regions (HCDR1, HCDR2, and HCDR3) contained in SEQ ID NO:
- 902 and a set of light chain complementarity determining regions (LCDR1, LCDR2, and LCDR3) contained in SEQ ID NO:
- 916.
Dependencies are inferred from the claim text.